Ingenia Therapeutics (950260) fully recovered from an early plunge on its first day of trading on the KOSDAQ, closing up nearly 50% from its initial public offering price.

According to the Korea Exchange on the 18th, Ingenia Therapeutics finished trading at 17,990 won, up 5,990 won (49.92%) from its offering price of 12,000 won. The closing price matched the intraday high.

■ Trading Began With a Decline

The start was the exact opposite. The stock began its first trade at 10,960 won, 1,040 won (8.67%) below the offering price. In early trading, the decline deepened, with the stock falling to 9,900 won — 17.5% below the offering price.

■ Reversal at 9:40 a.m.

The turning point came at 9:40 a.m. After the stock shifted into an uptrend, strong buying flowed in, allowing it to recover the offering price. It then steadily extended gains, ultimately closing its debut session at 17,990 won. Comparing the intraday low of 9,990 won with the closing price, the stock showed a dramatic swing within a single day.

■ Caution Needed on Volatility of Newly Listed Stocks

Newly listed stocks can exhibit large price volatility depending on early-stage circulating shares, investor sentiment, and short-term supply and demand, making it difficult to judge future trends based on the day's gain alone. In particular, on the first trading day of an IPO, the gap between the corporate value formed during the IPO pricing process and the price investors actually assign in the market can adjust rapidly. Ingenia Therapeutics also fell well below its offering price early in the session before sentiment completely reversed intraday, showing strong volatility on its listing debut.

[This article was written with AI assistance. It is based on provided market information and does not recommend buying or selling any specific stock. Newly listed stocks can be highly volatile depending on supply and demand, so investors are advised to review related disclosures and the latest market information before making investment decisions.]